Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | Arthritis Research & Therapy

Figure 3

From: CD97 neutralisation increases resistance to collagen-induced arthritis in mice

Figure 3

CD97 monoclonal antibody (mAb) treatment protects against inflammation and erosion when treatment is started at the onset of symptoms. Mice were treated with NaCl, 0.5 mg control immunoglobulin (cIg), or 0.5 mg anti-CD97 mAb. Paws (n = 8 to 12 mice per group) were stained with haematoxylin and eosin. (a) Representative examples of joints showing intact (left) and destructed (right) cartilage derived from mice treated from day 21 on with 0.5 mg CD97 mAb or cIg, respectively. Infiltration (b,c) and erosion (d,e) scores of mice treated from day 21 (b,d) or day 35 (c,e) on. Values are mean ± standard error of the mean. *P < 0.05.

Back to article page